Evidence map›Paper›PMID 30363681›Full record

ArticleBJR case reports2016

Radioiodine therapy under rhTSH for follicular thyroid carcinoma with sellar metastasis and non-rising TSH.

Sameer Kamalakar Taywade, Nishikant Avinash Damle, Kunal Kumar, Piyush Ranjan, Shipra Aggarwal, Chandrasekhar Bal, Amandeep Kumar, Devasenathipathi Kandasamy

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BJR case reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sameer Kamalakar TaywadeDepartment of Nuclear Medicine, A.I.I.M.S, New Delhi, India.
Nishikant Avinash DamleDepartment of Nuclear Medicine, A.I.I.M.S, New Delhi, India.
Kunal KumarDepartment of Nuclear Medicine, A.I.I.M.S, New Delhi, India.
Piyush RanjanDepartment of Surgery, A.I.I.M.S, New Delhi, India.
Shipra AggarwalDepartment of Pathology, A.I.I.M.S, New Delhi, India.
Chandrasekhar BalDepartment of Nuclear Medicine, A.I.I.M.S, New Delhi, India.
Amandeep KumarDepartment of Neurosurgery, A.I.I.M.S, New Delhi, India.
Devasenathipathi KandasamyDepartment of Radiodiagnosis, A.I.I.M.S, New Delhi, India.
Voluntary Health Association Of India · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastasis to the pituitary gland/sella turcica is an uncommon complication of thyroid cancer. Treating this condition is a challenge in the setting of pituitary insufficiency due to this lesion, and recombinant human thyroid-stimulating hormone (rhTSH) stimulation becomes critically essential. We present a rare case of an 82-year-old female patient with follicular carcinoma of the thyroid with metastasis to the sella turcica in addition to multiple skeletal and lung metastases. MRI of the brain showed a hypointense suprasellar lesion on

Identifiers

PMID30363681
PMCPMC6180898
OpenAlexW2254263387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.